- Home
- CI
as 07-26-2024 4:00pm EST
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense, and it recently won a deal with top-tier insurer Centene. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, and the company operates mostly in the US with 18 million US medical members covered as of December 2023.
Upcoming Earnings Alert:
Get ready for potential market movements as The Cigna Group CI prepares to release earnings report on 01 Aug 2024.
| Founded: | 1792 | Country: | United States |
| Employees: | N/A | City: | BLOOMFIELD |
| Market Cap: | 94.7B | IPO Year: | N/A |
| Target Price: | $380.06 | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 19 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 12.19 | EPS Growth: | -44.72 |
| 52 Week Low/High: | $253.95 - $365.71 | Next Earning Date: | 08-01-2024 |
| Revenue: | $206,003,000,000 | Revenue Growth: | 12.55% |
| Revenue Growth (this year): | 24.29% | Revenue Growth (next year): | 5.00% |
Stock Insider Trading Activity of The Cigna Group (CI)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Evanko Brian C | CI | See Remarks | Jun 24 '24 | Sell | $345.01 | 4,795 | $1,654,302.81 | 39,923 | SEC Form 4 |
| Granger Elder | CI | Director | Jun 17 '24 | Sell | $331.38 | 547 | $181,264.86 | 5,471 | SEC Form 4 |
| Granger Elder | CI | Director | Jun 12 '24 | Sell | $338.08 | 1,000 | $338,080.00 | 5,471 | SEC Form 4 |
| Eder Noelle K | CI | See Remarks | May 14 '24 | Sell | $348.47 | 10,700 | $3,728,629.00 | 15,824 | SEC Form 4 |
| Cordani David | CI | Chairman & CEO | Mar 21 '24 | Sell | $355.02 | 2,293 | $814,051.69 | 348,054 | SEC Form 4 |
| Cordani David | CI | Chairman & CEO | Mar 21 '24 | Sell | $355.11 | 6,338 | $2,250,682.11 | 348,054 | SEC Form 4 |
| Cordani David | CI | Chairman & CEO | Mar 21 '24 | Sell | $355.17 | 31,209 | $11,084,356.97 | 348,054 | SEC Form 4 |
| Cordani David | CI | Chairman & CEO | Mar 12 '24 | Sell | $345.00 | 2,238 | $772,120.97 | 340,438 | SEC Form 4 |
| Cordani David | CI | Chairman & CEO | Mar 12 '24 | Sell | $345.67 | 789 | $272,730.00 | 353,410 | SEC Form 4 |
| Cordani David | CI | Chairman & CEO | Mar 12 '24 | Sell | $348.66 | 892 | $311,003.38 | 352,518 | SEC Form 4 |
| Cordani David | CI | Chairman & CEO | Mar 12 '24 | Sell | $346.88 | 4,972 | $1,724,682.89 | 347,546 | SEC Form 4 |
| Cordani David | CI | Chairman & CEO | Mar 12 '24 | Sell | $347.65 | 7,108 | $2,471,125.34 | 340,438 | SEC Form 4 |
| Cordani David | CI | Chairman & CEO | Mar 7 '24 | Sell | $346.65 | 600 | $207,991.98 | 342,250 | SEC Form 4 |
| Cordani David | CI | Chairman & CEO | Mar 7 '24 | Sell | $345.42 | 1,812 | $625,900.50 | 340,438 | SEC Form 4 |
| Cordani David | CI | Chairman & CEO | Mar 7 '24 | Sell | $345.19 | 2,801 | $966,883.07 | 340,438 | SEC Form 4 |
| Cordani David | CI | Chairman & CEO | Mar 1 '24 | Sell | $332.62 | 19,288 | $6,415,574.56 | 340,438 | SEC Form 4 |
| Jones Nicole S | CI | See Remarks | Mar 1 '24 | Sell | $332.62 | 4,436 | $1,475,502.32 | 31,587 | SEC Form 4 |
| Triplett Michael W | CI | Special Advisor | Mar 1 '24 | Sell | $332.62 | 1,953 | $649,606.86 | 32,452 | SEC Form 4 |
| Cordani David | CI | Chairman & CEO | Feb 23 '24 | Sell | $345.24 | 6,319 | $2,181,592.41 | 336,783 | SEC Form 4 |
| Cordani David | CI | Chairman & CEO | Feb 23 '24 | Sell | $347.14 | 100 | $34,713.50 | 347,136 | SEC Form 4 |
| Cordani David | CI | Chairman & CEO | Feb 23 '24 | Sell | $346.38 | 3,524 | $1,220,640.65 | 343,612 | SEC Form 4 |
| Cordani David | CI | Chairman & CEO | Feb 23 '24 | Sell | $345.34 | 6,829 | $2,358,298.18 | 336,783 | SEC Form 4 |
| Cordani David | CI | Chairman & CEO | Feb 23 '24 | Sell | $345.04 | 2,000 | $690,075.00 | 336,783 | SEC Form 4 |
| Palmer Eric P | CI | See Remarks | Feb 13 '24 | Sell | $340.00 | 6,083 | $2,068,220.00 | 44,649 | SEC Form 4 |
| Palmer Eric P | CI | See Remarks | Feb 9 '24 | Sell | $335.26 | 1,017 | $340,956.17 | 45,564 | SEC Form 4 |
Latest The Cigna Group News
CI Breaking Stock News: Dive into CI Ticker-Specific Updates for Smart Investing
Zacks
11 hours ago
Zacks Industry Outlook Highlights UnitedHealth, The Cigna and Centene
Zacks
11 hours ago
Is Cigna Group (CI) Outperforming Other Medical Stocks This Year?
Zacks
a day ago
Molina Healthcare (MOH) Q2 Earnings Beat on Growing Membership
Zacks
a day ago
Cigna (CI) Reports Next Week: Wall Street Expects Earnings Growth
Zacks
a day ago
3 HMO Stocks Set to Thrive on a Varied Customer Base, Tech Investments
PR Newswire
2 days ago
The Cigna Group Declares Quarterly Dividend
Healthcare Dive
3 days ago
PBMs battle bipartisan scrutiny as lawmakers eye industry reform
Argus Research
3 days ago
CI: Lowering target price to $370.00
Compare CI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CI The Cigna Group - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.